Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 5/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 4/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 4/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.37 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22319094 | 0.79 | MAPK1 (0.41) | CYP2C19HIF1ATAAR1KCNN4MAPK1 | |
| SCHEMBL22730191 | 0.72 | CYP2C19 (0.35) | CYP2C19HIF1ATAAR1GRIN1GRIN2A | |
| SCHEMBL22730161 | 0.71 | CYP2C19 (0.34) | CYP2C19HIF1ATAAR1GRIN1GRIN2A | |
| SCHEMBL995710 | 0.68 | KIF11 (0.42) | CYP2C19HIF1ATAAR1GRIN1GRIN2A | |
| SCHEMBL6682969 | 0.68 | KIF11 (0.42) | CYP2C19HIF1ATAAR1GRIN1GRIN2A | |
| SCHEMBL3087077 | 0.68 | KIF11 (0.42) | CYP2C19HIF1ATAAR1GRIN1GRIN2A | |
| SCHEMBL22730183 | 0.68 | CYP2C19 (0.35) | CYP2C19HIF1ATAAR1GRIN1GRIN2A | |
| SCHEMBL22730174 | 0.68 | MAPK1 (0.35) | CYP2C19HIF1ATAAR1KCNN4MAPK1 | |
| SCHEMBL22734822 | 0.67 | CYP2C19 (0.41) | CYP2C19HIF1ATAAR1KCNN4MAPK1 | |
| SCHEMBL22734818 | 0.67 | CYP2C19 (0.41) | CYP2C19HIF1ATAAR1KCNN4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111164092-B | Process for producing peptide compound | 日产化学株式会社 | 2023-12-26 | — | — | CN | disclosed |
| US-20200291061-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | NISSAN CHEMICAL CORPORATION (JP) | 2020-09-17 | — | — | US | disclosed |
| EP-3693377-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | Nissan Chemical Corporation (JP) | 2020-08-12 | — | — | EP | disclosed |
| CN-111164092-A | Method for producing peptide compound | 日产化学株式会社 | 2020-05-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200291061-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | VIP, NGLY1, IAPP | CYP2C19 3871/4885HIF1A 1367/4885TAAR1 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.